Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

Novo Nordisk’s annual results are out and they ... The Copenhagen-based company’s revenue was equal to 10% of Denmark’s GDP last year. They turned that DKK 290 billion in revenue into ...

The pens will be returned to Novo Nordisk's facilities in Denmark – on the same boat that drops them off in the UK – and the plastic will be recycled into a range of items, such as chairs ...

Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to fall by over a fifth, wiping around $94 billion off its market cap.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The 29-year-old woman, a member of the Danish Parliament, is one of the most well-known political figures from the Greenlandic part of the Kingdom of Denmark.Today ... and investment in the United ...

A new agreement in Denmark’s industrial sector was found between Dansk Industri and CO-industry, a federation of labor unions representing employees in the industrial sector. These agreements will ...